Get started
Author

Koichi Fukuda

Observed names: K Fukuda, K. FUKUDA
ORCID: 0000-0001-5044-8880
Observed ORCID: 0000-0001-5044-8880
OpenAlex ID: A5069746203
Present and Future Post-marketing Drug Safety Assessment in Japan: A PMDA Perspective
2026 · Takashi Waki, Shinya Watanabe, et al. · Therapeutic Innovation & Regulatory Science · 3
PDF
Decision and timing of safety‐related labeling changes for new drugs in Japan: Comparison with the United States and the European Union
2023 · Koichi Fukuda, Mamoru Narukawa · Pharmacoepidemiology and Drug Safety · 2
Background Factors Contributing to Safety Warning Discordance in the Initial Labeling of New Drugs in Japan, the United States, and the European Union
2024 · Koichi Fukuda, Mamoru Narukawa · Clinical Pharmacology & Therapeutics · 1
[Presynaptic and postsynaptic mechanisms of phosphoinositide metabolites].
1990 · H Higashida, N Hoshi, et al. · PubMed · 1
ChemInform Abstract: Synthesis and Activity of Staurosporine Analogues with a Lactone Functionality.
1996 · R. YAMADA, K. FUKUDA, et al. · ChemInform
[Usefulness of ceftazidime in intractable respiratory tract infections].
1989 · S Takenaka, K Fukuda, et al. · PubMed
Works count: 6
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type